Navigation Links
Study Supports Selective Use of Drug-Coated Stents
Date:8/15/2011

MONDAY, Aug. 15 (HealthDay News) -- Limiting the use of expensive drug-eluting (coated) stents does not increase patients' risk of heart attack or death, but it can save the U.S. health care system hundreds of millions of dollars a year, a new study suggests.

A stent is a mesh tube used to keep an artery open after a procedure to unblock clogged or narrowed arteries (angioplasty). A drug-eluting stent is coated with medicine to prevent blood clots. Research has shown that drug-eluting stents are better than bare-metal stents at preventing re-narrowing of arteries, according to background information in the study.

The current study examined the effects of selective use of drug-eluting stents, which began in the United States in 2007. The researchers analyzed data from 10,144 patients who underwent angioplasty at 55 medical centers across the nation between 2004 and 2007.

The use of drug-eluting stents decreased from 92 percent of angioplasty patients in 2004-2006 to 68 percent in 2007, but rates of heart attack and death remained virtually the same. Procedures to re-treat a blockage at the same coronary artery site increased from 4.1 percent to 5.1 percent.

The researchers also found that selective use of drug-eluting stents saves the nation's health care system about $400 million a year.

The study is published online Aug. 15 in the journal Circulation.

"The bottom-line was that using drug-eluting stents in a relatively unselected way was only resulting in marginal improvement compared to more selective use," senior author Dr. David J. Cohen, director of cardiovascular research at Saint Luke's Mid America Heart and Vascular Institute in Kansas City, Mo., said in a journal news release.

More information

The U.S. National Heart, Lung, and Blood Institute has more about stents.

-- Robert Preidt

SOURCE: American Heart Association, news release, Aug. 15, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Vitamin D Levels Linked to Certain Skin Cancers, Study Finds
2. Study suggests seeing a neurologist helps people with Parkinsons live longer
3. Music Eases Cancer Patients Anxiety: Study
4. Cardiologists Often Miss Heart Defects in Young Athletes: Study
5. Common themes emerge in hospitals anti-MRSA efforts: Study
6. Prehistoric Water Reptiles Social Life Similar to Dolphins: Study
7. Women Born After Great Depression Had More Children, Study Finds
8. Study Pits New Blood Thinner Against Warfarin For Irregular Heartbeat
9. Study finds marked rise in intensely sexualized images of women, not men
10. Breast Cancer Drug Raises Risk of Heart Problems in Older Women: Study
11. Daily Hot Dog May Feed Diabetes Risk: Study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study Supports Selective Use of Drug-Coated Stents 
(Date:2/13/2016)... , ... February 13, 2016 , ... Hidden Cypress in Sun City is the place ... facial plastic surgery. Dr. Frederick Weniger will be hosting this educational seminar from ... event, and there will be special pricing on offers. In addition, prizes will be given ...
(Date:2/13/2016)... (PRWEB) , ... February 13, 2016 , ... The producers ... impact of American businesses. , The increasingly modern world of instantaneous consumption proves ... on non-renewable energy sources such as oil and coal, which pollutes our air, water, ...
(Date:2/13/2016)... ... 13, 2016 , ... DDi , a Makro company, ... for its expertise in eClinical Solutions. DDi has built its solution competency with ... of global clients. DDi provides smarter technology for Clinical Development, Regulatory and Enterprise ...
(Date:2/12/2016)... ... February 12, 2016 , ... The Lymphoma ... innovative lymphoma research and serving the lymphoma community through a comprehensive series of ... South Florida’s philanthropic community at its 10th anniversary Fashion Luncheon on Monday, February ...
(Date:2/12/2016)... , ... February 12, 2016 , ... Coco Libre, the ... in Red Carpet Events LA GRAMMY’s Style Lounge Event. Coco Libre will offer musicians ... stay hydrated before the big event. The invitation-only gifting suite, held this year at ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... and Company (NYSE: LLY ) today announced that the ... patent would not presently be infringed by Actavis marketing pemetrexed ... Italy and Spain ... --> --> In ... Lilly,s patent would be indirectly infringed by Actavis marketing certain ...
(Date:2/12/2016)... , Feb. 12, 2016  Apellis Pharmaceuticals, ... a $47.1 million Series D preferred stock ... Management, Hillhouse Capital Group and venBio Global ... Investments, AJU IB Investment, and Epidarex Capital. The ... to further advance clinical trials in the ...
(Date:2/11/2016)... , Feb. 11, 2016 The primary goal ... future adoption patterns on the usage of liquid biopsy. ... following: - Timeframe of liquid biopsy adoption ... cfDNA and Evs—by organization type - Sample inflow to ... blood, saliva, stool, serum, and so on. - Correlation ...
Breaking Medicine Technology: